Jurgen Kuball

Full Professor

Strategic program(s):

Biography

Prof. Dr. Jürgen Kuball received his medical degree as hematologists at the University of Mainz, Germany, and was further trained at the Fred Hutchinson Cancer Center in Seattle, WA, USA. Prof. Kuball joined the Department of Hematology at the University Medical Center in Utrecht in The Netherlands in 2007 as hematologists and immunologist. He became a VIDI-laureate in 2010 and chairs the section applied & tumor-immunology within the laboratory of translation immunology. Since 2013 he is chairing the Department of Hematology (adults). His clinical activities are focusing on treating patients with hematological malignancies including stem cell transplantation. His clinical-translational efforts and patient care are driven by his role as Director of the Bone Marrow Transplantation Program at the University Medical Center Utrecht, as well as active membership of the leukemia working party and stem cell working party of HOVON. His current laboratory activities are focusing on the understanding of innate immune cells and their receptors to recognize malignant cells and virally infected cells as well as the genetic engineering of a transplant.

For more information on experimental and translational research please visit Kuball Laboratories

Strategic program(s):

Contact

jkuball@umcutrecht.nl

Pure profile

Research groups

Tumor Immunology

Research aim

Our research aims to revolutionise cancer treatment by advancing innovative immunotherapies, ensuring safer, more effective therapies, and improving patient outcomes, ultimately transforming lives through cutting-edge translational cancer research.

Go to group

Recent publications

All publications

Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe Nicole Santoro, Christoph Schmid, Moniek de Witte, Mieke W H Roeven, Victoria Potter, Deborah Richardson, Thomas Schroeder, Veronika Válková, Katherine Clesham, Sandrine Loron, Jakob Passweg, Caroline Besley, Bernd Gruhn, Jorinde D Hoogenboom, Jarl E Mooyaart, Isabel Sanchez-Ortega, Simona Pagliuca, Federico Simonetta, Giorgia Battipaglia, Thierry Guillaume, Mette D Hazenberg, Florent Malard, Jürgen Kuball, Annalisa Ruggeri
Bone Marrow Transplantation, 2025, vol. 60, p.697-701

Improved GVHD-free and relapse-free survival after ex vivo αβTCR and CD19 depleted allogeneic HSCT compared to T cell replete HSCT A H G Stuut, C Nijssen, L van der Wagen, A van Rhenen, L G M Daenen, A Janssen, F A Verheij, I Brinkman, F M Verduyn Lunel, H Koene, R Fijnheer, H J Prins, K Westinga, J Drylewicz, J Kuball, M A de Witte
Bone Marrow Transplantation, 2025, vol. 60, p.673-681

The use of MSCs in steroid-refractory acute GvHD in Europe L G M Daenen, L E van der Wagen, E F Bonneville, L López-Corral, A Bukauskas, M Bornhäuser, Y Beguin, M Itäla-Remes, J D Hoogenboom, L C de Wreede, F Malard, C Chabannon, F Dazzi, A Ruggeri, J Kuball
Bone Marrow Transplantation, 2025, vol. 60, p.708-714

Definitions matter Konradin F. Müskens, Winny N.R. Collot-d'Escury, Rana Dandis, Saskia Haitjema, Jürgen Kuball, Moniek A. de Witte, Marc Bierings, Caroline A. Lindemans, Stefan Nierkens, Mirjam E. Belderbos
Hemasphere, 2024, vol. 8

Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation Annoek E C Broers, Ellen Meijer, Bronno van der Holt, Cornelis N de Jong, Erfan Nur, Geerte L van Sluis, Goda Choi, Michel van Gelder, Johan A Maertens, Jürgen Kuball, Dries Deeren, Heleen A Visser-Wisselaar, Lamberdina A H M Meulendijks, Jan J Cornelissen,
Hemasphere, 2024, vol. 8

Biological Aspects Chiara Bonini, Raffaella Greco, Jürgen Kuball
2024, p.55

Fellowships & Awards

American Association of Cancer Research-GlaxoSmithKline Scholar in Cancer Research Award (2001)
Stipendiat der Deutschen Krebshilfe (2005-2007)
Team Science recognition award of the „Society for Immunotherapy of Cancer“ to Jürgen Kuball and the University of Washington, USA (2010)
VIDI-Laureate ZonMW, The Netherlands (2010)

External positions

aandeelhouder - shareholder via Gadeta Founders - Century Therapeutics & Adeta

Chair - Chairing - Immunology Community Life Science

Secretary team member - bestuurslid - GoCART Coalition (EBMT/EHA)

Inkomsten licentie - Onderzoek - UMCU Holding

Commissie lid PPS commissie - grant indieningen voor KWF beoordelen - KWF

aandeelhouder - Receiving revenues from licensed patents via UMCU - UMC Holding

Chair legal and rgulatory affairs committee - Chair - EBMT

grant - grant ontvangen voor onderzoek - Novartis

Onderzoeker - grant ontvangen voor onderzoek - Miltenyi

bestuurslid - member general Board - HOVON

Patent holder multipe inventions licensed to Gadeta-follow up company Century Therapeuitcs &Miltenyi - Patent houder - Various